Pixelated gene expression tool provides fast accurate results for RNA analysis

Posted: 22 January 2018 | | No comments yet

Researchers have demonstrated how a pixelated gene expression tool can accurately measure RNA levels more quickly than existing methods allow.

pixelated gene expression

A University of Illinois and Mayo collaboration has demonstrated a novel gene expression analysis technique that can accurately measure levels of RNA quickly and directly from a cancerous tissue sample, while preserving the spatial information across the tissue – something that conventional methods can’t achieve.

According to Illinois Bioengineering Professor and co-leader of the research team, Rashid Bashir, existing gene expression methods have limitations. “They are cumbersome and slow, taking hours or even many days to do the analysis across just one tissue sample,” he said.

Our technique does the entire analysis across the tissue slice in two hours or less.”

Existing methods can measure proteins that are produced after genetic information or instructions have flowed from DNA and RNA. Those protein-measuring methods are complicated and require antibodies that don’t exist for all proteins.

“Our method can detect messenger RNA expression, which can provide additional insight than just the final protein concentration,” said Bashir.

Pixelated spatial gene expression

The pixelated spatial gene expression tool can analyse an entire tissue sample and identify cancer cells in a process that takes less than two hours.
Research team co-lead Dr. Farhad Kosari – an assistant professor of biochemistry and molecular biology at Mayo Clinic – envisions their new technique could eventually be used in research labs as well as the clinic. “If you were studying tumour microenvironments, you’d want to know what genes are expressed at a specific location of the tumour,” said Kosari. “This ability to look at localised expression of genes is currently done with fluorescence in situ hybridisation (FISH), but our technique is a lot faster and more quantitative.”

In addition, the messenger RNA (mRNA) will elicit more accurate genetic information. “When analysing animal models and xenografts, there can be cross reactivity of the target antibody with the host antigen, leading to false positive signals and error in analysis,” said Illinois Bioengineering doctoral student Anurup Ganguli, the first author of the study.

The team created a fingernail-sized silicon chip that contains an array of more than 5,000 pyramid-shaped wells with razor-sharp edges. When a centimetre-sized cancer tissue sample is placed on the chip it is automatically cut up into hundreds or thousands of tiny pieces that are analysed in parallel using an existing technology known as loop mediated isothermal amplification (LAMP).

A streamlined process

According to Ganguli, once the tissue is cut and placed into the underlying wells on the microchip, thousands of independent picolitre volume LAMP reactions are performed in each well directly from the tissue, without the need for any analyte purification.

“Laser capture microdissection (LCM) followed by downstream purification and amplification has been used in the past to look at specific regions of stained tissue samples and analyse the heterogeneity within the sample,” Kosari said. “Our technique is similar to performing more than 5,000 LCM steps with the downstream amplification in a single step on a microchip.”

Ganguli demonstrated the new pixelated technique using frozen human prostate tissue xenografts grown in mice. In less than two hours, he was able to amplify and analyse the mRNA of TOP2A, a nuclear enzyme and known marker of prostate cancer’s aggressiveness.

“Our approach pixelates the entire tissue sample and can identify those very few cells that may be cancerous,” said Bashir. “There isn’t any technique in existence that takes raw tissue to nucleic acid amplification while keeping the spatial information preserved.”

The new technique may also be useful someday for helping physicians and pathologists determine tumour margins, which could enhance the outcome of cancer surgeries.